Dimensional Fund Advisors LP Marker Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.37 - $1.0 $24,067 - $65,048	-65,048 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$0.95 - $1.72 $79,195 - $143,386	-83,364 Reduced 56.17%	65,048 $62,000
Q3 2021 Nov 12, 2021	BUY	$1.68 - $2.88 $134,500 - $230,572	80,060 Added 117.13%	148,412 $251,000
Q2 2021 Aug 12, 2021	BUY	$1.88 - $3.56 $23,934 - $45,322	12,731 Added 22.89%	68,352 $191,000
Q4 2020 Feb 25, 2021	BUY	$1.36 - $1.75 $75,644 - $97,336	55,621 New	55,621 $81,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $269M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.